According to a literature review published in the journal of Neurotoxicity Research, cannabinoids, provide a potential multi-targeted treatment strategy for patients with Parkinson’s disease and dyskinesia.
Picture Source : WebMD/3D4 Medical
https://link.springer.com/article/10.1007%2Fs12640-019-00109-8
